Galmed Pharmaceuticals(GLMD) - 2019 Q2 - Earnings Call Transcript

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Q2 2019 Earnings Conference Call August 5, 2019 8:30 AM ET Company Participants Allen Baharaff - President and Chief Executive Officer Yohai Stenzler - Chief Financial Officer Tali Gorfine - Chief Medical Officer Liat Hayardeny - Chief Scientific Officer Conference Call Participants Yasmeen Rahimi - Roth Capital Partners Adam Walsh - Stifel Steve Seedhouse - Raymond James Ed Arce - H.C. Wainwright Mayank Mamtani - B. Riley FBR Operator Good day, and welcome to the G ...